*Stock Score changes are based on previous closing prices
Financhill
Back

PTC Therapeutics 10K Form

Buy
55

PTCT
PTC Therapeutics

Last Price:
41.83
Seasonality Move:
12.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PTCT News And Ratings

See the #1 stock for the next 7 days that we like better than PTCT

PTCT Financial Statistics

Sales & Book Value

Annual Sales: $538.59M
Cash Flow: $-178.85M
Price / Cash Flow: 0
Annual Sales: $-1.27
Price / Book: 0

Profitability

EPS (TTM): -7.38000
Net Income (TTM): $-521.99M
Gross Margin: $506.27M
Return on Equity: -516.88%
Return on Assets: -26.32%

PTC Therapeutics Earnings Forecast

Key PTC Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 9 years for PTCT is 94.00%.
  • The Selling, General & Administrative Expenses for PTCT have been equal to 53.06% of Gross Profit Margin.
  • The Research & Development expenses have been 100.39% of Revenue.
  • The Interest Expense is -16.42% of Operating Income.
  • The Net Earning history of PTCT is -97.27% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

PTC Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: PTCT
CUSIP: 69366J
Website: ptcbio.com

Debt

Debt-to-Equity Ratio: -4.77
Current Ratio: 1.62
Quick Ratio: 1.53

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTCT Technical Analysis vs Fundamental Analysis

Buy
55
PTC Therapeutics (PTCT) is a Buy

Is PTC Therapeutics a Buy or a Sell?

  • PTC Therapeutics stock is rated a Buy
    The current PTC Therapeutics [PTCT] share price is $41.85. The Score for PTCT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.